SCHEMBL24159538

SCHEMBL24159538

Cc1nc(I)c2ccoc2n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HPGD P15428 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36
▸ TUBA4A P68366 1/20 0.36
▸ TUBB4B P68371 1/20 0.36
▸ TUBB3 Q13509 1/20 0.36
▸ TUBB2A Q13885 1/20 0.36
▸ TUBB8 Q3ZCM7 1/20 0.36
▸ TUBA3E Q6PEY2 1/20 0.36
▸ TUBA1A Q71U36 1/20 0.36
▸ TUBA1C Q9BQE3 1/20 0.36
▸ TUBB6 Q9BUF5 1/20 0.36
▸ TUBB2B Q9BVA1 1/20 0.36
▸ TUBB1 Q9H4B7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14213487 0.79 KDM4E (0.38) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL8984097 0.76 KDM4E (0.36) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL24175234 0.73 EGFR (0.36) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL24175624 0.69 KDM4E (0.35) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL24704435 0.68 SOS1 (0.40) KDM4EMEN1KMT2ATSHREGFR
SCHEMBL19661009 0.68 LMNA (0.30) LMNA
SCHEMBL24802390 0.68 KDR (0.49) KDM4EALDH1A1EGFRKDRPDGFRA
SCHEMBL12559880 0.67 DRD1 (0.36) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL19779973 0.65 CYP1A2 (0.44) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL13169636 0.64 GPR3 (0.50) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4186895-A1 COMPOUND USEFUL AS CDK7 KINASE INHIBITOR AND USE THEREOF TYK Medicines Inc. (CN) 2023-05-31 — — EP disclosed
EP-3932404-A1 METHOD FOR TREATING FATTY LIVER DISEASE AND/OR STEATOHEPATITIS Beijing Tide Pharmaceutical Co., Ltd. (CN) 2022-01-05 — — EP disclosed
Send feedback